M020-1103 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]benzene-1-sulfonamide

M020-1103 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]benzene-1-sulfonamide
M020-1103 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M020-1103
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M020-1103

Molecular Formula

C23H19N3O5S (C23 H19 N3 O5 S)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]benzene-1-sulfonamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-3-[3-(4-methylphenyl)-124-oxadiazol-5-yl]benzene-1-sulfonamide

SMILES

Cc(cc1)ccc1-c1noc(-c2cccc(S(Nc(cc3)cc4c3OCCO4)(=O)=O)c2)n1

InChI

InChI=1S/C23H19N3O5S/c1-15-5-7-16(8-6-15)22-24-23(31-25-22)17-3-2-4-19(13-17)32(27,28)26-18-9-10-20-21(14-18)30-12-11-29-20/h2-10,13-14,26H,11-12H2,1H3

InChI Key

UEDNBNKYOMJWFJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27492791

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.255

Distribution Coefficient, logD

4.051

Water Solubility, LogSw

-4.35

Polar Surface Area

88.117

Acid Dissociation Constant (pKa)

7.62

Base Dissociation Constant (pKb)

-5.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

M020-1103 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with M020-1103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M020-1103?
Check Price and Availability of M020-1103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M020-1103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M020-1103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M020-1103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M020-1103 available by request